Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Identification of candidate odorant degrading gene/enzyme systems in the antennal transcriptome of Drosophila melanogaster
The deal values MTSR at ~$4.9B upfront and up to $7.3B based on milestones outlined in a contingent value right (CVR)
Based on Lilly's precedent with tirzepatide, retatrutide will likely receive separate brand names for different indications: Tirzepatide became Mounjaro for type 2 diabetes and Zepbound for obesity Retatrutide is expected to follow the same pattern with distinct brand names per indication Brand names are typically announced closer to the FDA approval date or during the NDA review period
Do not stop or adjust Ozempic or other GLP-1 medications without medical advice, even if sulfur burps become bothersome
Amato and Dr
